Crystalline Form 1 '- (1-methylethyl) - 4' - (2 - fluoro - 4-methoxyphenyl) methyl - 4 '- methyl) - 1H pyrazole - 3' - d or - beta - glucopiranosido and preparation method

摘要

Refers to a Crystalline Form 1 '- (1-methylethyl) - 4' - [(2 - fluoro - 4-methoxyphenyl) methyl] - 4 '- methyl) - 1H pyrazole - 3' - d or - beta - glucopiranosido characterised by presenting a pattern of x-ray diffraction Powder includes Peaks to 5.35; 8,93; 10.76 16.20 and 19.81 degrees; 2. (+ / - 0.1 degrees)Where the Crystal form contains Water in an interval from 0 to 10% by weight and at least 50% by weight is present as critalina.It also relates to a Pharmaceutical Composition and a method for preparing the Crystalline form, The Compound is an inhibitor of the sodium dependent glucose cotransporter sglt2, so it is useful in the treatment of Metabolic Disorders such as diabetes